Project Details


SimvaStatin in Neurofibromatosis Type 1- Autism was a research study looking at the use of the drug Simvastatin in children with NF1 and Autism Spectrum Disorders (ASD).

Phase II was an exploratory study of statin treatment in young children aged 5-8 years with NF1 and autism. The purpose of this study is to test acceptability and feasibility of involvement for families and the feasibility of imaging young children with NF1 autism.

For more information please see the trial protocol.
Short titleR:KAF GREJ12
Effective start/end date1/12/1231/05/17

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.